Financials
- Market Capitalization 79.5 M
- Employee 128
- Founded 1983
- CEO N/A
- Website www.herontx.com
- Headquarter Delaware, United States
- FIGI BBG000G2GJT7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4077 | ACET Adicet Bio, Inc. - Common Stock | 8.78 USD | +2.69% | -0.23% | +8.13% | +1055.26% | 82.08 M USD | ||
| 4082 | CSBR Champions Oncology, Inc. - Common Stock | 5.78 USD | -0.52% | -2.86% | -10.94% | -28.20% | 80.27 M USD | ||
| 4102 | RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.66 USD | +4.76% | -15.38% | -17.50% | +34.69% | 81.76 M USD | ||
| 4104 | ENTX Entera Bio Ltd. - Ordinary Shares | 1.66 USD | +1.22% | -1.19% | +32.80% | -6.21% | 81.71 M USD |
Frequently asked questions about Heron Therapeutics, Inc. - Common Stock
What is the Heron Therapeutics, Inc. - Common Stock stock price today?
The current price of Heron Therapeutics, Inc. - Common Stock (HRTX) is 0.42. Over the past 24 hours, the stock has changed by 0.00%. Follow the HRTX chart for real-time price dynamics.
What is the stock ticker of Heron Therapeutics, Inc. - Common Stock?
Heron Therapeutics, Inc. - Common Stock trades under the ticker HRTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Heron Therapeutics, Inc. - Common Stock stock going up?
HRTX has changed by 0.00% over the last week, 0.00% over the last month, and -80.19% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Heron Therapeutics, Inc. - Common Stock net income for the last quarter?
Heron Therapeutics, Inc. - Common Stock reported net income of -8.11 M for the last quarter. The previous quarter showed -2.95 M, which means net income changed by -174.58%.
How many employees does Heron Therapeutics, Inc. - Common Stock have?
As of the latest available data, Heron Therapeutics, Inc. - Common Stock has 128 employees. Workforce size can provide additional context about the company's scale and operations.
What is Heron Therapeutics, Inc. - Common Stock EBITDA?
Heron Therapeutics, Inc. - Common Stock EBITDA is 6.4 M, and its EBITDA margin is 18.44%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Heron Therapeutics, Inc. - Common Stock stock?
You can buy Heron Therapeutics, Inc. - Common Stock (HRTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Heron Therapeutics, Inc. - Common Stock stock?
Investing in Heron Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the HRTX chart and related analysis on metatrader.com as part of your research.